Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses

Phytomedicine

Volumn 16, Issue 1, 2009, Pages 35-39

  Choi, H J ^a   Lim, C H ^b   Song, J H ^c   Baek, S H ^c   Kwon, D H ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Antiviral activity; Raoulia australis; Raoulic acid

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; RAOULIC ACID; RIBAVIRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; ASSAY; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS B4; CYTOPATHOGENIC EFFECT; ENTEROVIRUS 71; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; IC 50; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MEDICINAL PLANT; NONHUMAN; PICORNAVIRUS; PRIORITY JOURNAL; RAOULIA AUSTRALIS;

ANTIVIRAL AGENTS; ASTERACEAE; HELA CELLS; HUMANS; PHYTOTHERAPY; RNA VIRUSES; TERPENES;

CERCOPITHECINE HERPESVIRUS 1; HUMAN ENTEROVIRUS 71; HUMAN RHINOVIRUS 2; HUMAN RHINOVIRUS 3; RAOULIA; RNA VIRUSES;

EID: 58149344941     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.10.012     Document Type: Article

References (12)

1. Andries K., Dewindt B., Snoeks J., Willebrords R., Stokbroekx R., and Lewi P.J. A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program. Antivir. Res. 16 (1991) 213-225
2. 25 terpene acid from Raoulia australis. Tetrahedron Lett. 34 (1993) 5617-5620
3. Bloor S.J. A Survey of extracts of New Zealand indigenous plants for selected biological activities. N. Z. J. Bot. 33 (1995) 523-540
4. De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol. 30 (2004) 115-133
5. Fendrick A.M., Monto A.S., Nightengale B., and Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Intern. Med. 163 (2003) 487-494
6. Hayden F.G. Antivirals for influenza: historical perspectives and lessons learned. Antivir. Res. 71 (2006) 372-378
7. Heikkinen T., and Jarvinen A. The common cold. Lancet 361 (2003) 51-59
8. Jassim S.A., and Naji M.A. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 95 (2003) 412-427
9. Lin Z.X., Hoult J.R.S., and Raman A. Sulforhodamine B assay for measuring proliferation of a pigmented melanocyte cell line and its application to the evaluation of crude drugs used in the treatment of vitiligo. J. Ethnopharmacol. 66 (1999) 141-150
10. Melnick J.L. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields B.N., Knipe D.M., Howley P.M., Channock R.M., Melnick J.L., Monath T.P., Roizman B., and Straus S.E. (Eds). Fields Virology (1996), Lippincott-Raven Publishers, Philadelphia, PA 655-712
11. Minor P.D., Brown F., Domingo E., Hoey E., King A., Knowles N., Lemon S., Palmenberg A., Rueckert R.R., Stanway G., Wimmer E., and Yin-Murphy M. Family Picornaviridae. In: Murphy F.A., Fauquet C.M., Bishop D.H.L., Ghabrial S.A., Jarvis A.W., Martelli G.P., Mayo M.A., and Summers M.D. (Eds). Virus Taxonomy, Classification and Nomenclature of Viruses (1995), Springer, Vienna, Austria 329-336
12. Palese P. Influenza: old and new threats. Nat. Med. 10 (2004) S82-S87